These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 28658981)

  • 21. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical management of alcohol use disorders].
    Paille F
    Rev Prat; 2019 Oct; 69(8):909-916. PubMed ID: 32237660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
    Kranzler HR
    Alcohol Alcohol; 2000; 35(6):537-47. PubMed ID: 11093959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol addiction - the safety of available approved treatment options.
    Antonelli M; Ferrulli A; Sestito L; Vassallo GA; Tarli C; Mosoni C; Rando MM; Mirijello A; Gasbarrini A; Addolorato G
    Expert Opin Drug Saf; 2018 Feb; 17(2):169-177. PubMed ID: 29120249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical and clinical pharmacology of alcohol dependence.
    Tambour S; Quertemont E
    Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Depression in alcohol addicted patients].
    Ponizovskiy PA; Gofman AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
    Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
    Johnson BA
    Biochem Pharmacol; 2008 Jan; 75(1):34-56. PubMed ID: 17880925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
    Heilig M; Egli M
    Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatment of alcohol dependence: a systematic review.
    Miller PM; Book SW; Stewart SH
    Int J Psychiatry Med; 2011; 42(3):227-66. PubMed ID: 22439295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
    Soyka M; Friede M; Schnitker J
    Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.